# A Study of Milvexian in Healthy Adult Females

> **NCT05706753** · PHASE1 · COMPLETED · sponsor: **Janssen Pharmaceutica N.V., Belgium** · enrollment: 20 (actual)

## Conditions studied

- Healthy Female

## Interventions

- **DRUG:** Milvexian
- **DRUG:** Midazolam
- **DRUG:** Ethinylestradiol
- **DRUG:** Drospirenone

## Key facts

- **NCT ID:** NCT05706753
- **Lead sponsor:** Janssen Pharmaceutica N.V., Belgium
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-01-25
- **Primary completion:** 2023-07-20
- **Final completion:** 2023-07-20
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2025-03-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05706753

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05706753, "A Study of Milvexian in Healthy Adult Females". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05706753. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*